Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results

<p>CHASKA, Minn., Aug. 31, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (Nasdaq: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported results for the fiscal 2023 fourth quarter and full year ended May 28, 2023. CEO COMMENTS: James G. Hall, President and Chief Executive Officer of Lifecore, commented, “We completed […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/lifecore-biomedical-reports-fourth-quarter-and-full-fiscal-year-2023-results/">Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>